aluates Reports

$ 7800.0

Automative

Global Oligonucleotide Process Development and Manufacturing Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-7A19364

BUY CHAPTERS

Global Oligonucleotide Process Development and Manufacturing Market Research Report 2025

Code: QYRE-Auto-7A19364

Report

March 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Oligonucleotide Process Development and Manufacturing Market Size

The global market for Oligonucleotide Process Development and Manufacturing was valued at US$ 1252 million in the year 2024 and is projected to reach a revised size of US$ 2148 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Oligonucleotide Process Development and Manufacturing Market

Oligonucleotides are short-chain nucleic acid molecules with extensive applications in gene therapy, vaccine development, and targeted therapies. Oligonucleotide process development involves the optimization of the entire production workflow, from nucleotide monomer synthesis and solid-phase synthesis to purification and final drug formulation, ensuring high purity, high yield, and scalability. Drug manufacturing must comply with Good Manufacturing Practices (GMP), including stringent quality control, sterile environments, and advanced process scale-up technologies to ensure the safety and efficacy of the final product. With the rapid advancement of nucleic acid therapeutics, efficient, cost-effective, and scalable process development is critical for accelerating new drug commercialization.

North American market for Oligonucleotide Process Development and Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oligonucleotide Process Development and Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Oligonucleotide Process Development and Manufacturing in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Oligonucleotide Process Development and Manufacturing include ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Nippon Shokubai, Eurogentec, Ajinomoto Bio-Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Process Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Process Development and Manufacturing.

The Oligonucleotide Process Development and Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide Process Development and Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oligonucleotide Process Development and Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oligonucleotide Process Development and Manufacturing Market Report

Report Metric	Details
Report Name	Oligonucleotide Process Development and Manufacturing Market
Accounted market size in year	US$ 1252 million
Forecasted market size in 2031	US$ 2148 million
CAGR	8.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oligonucleotide Process Development Oligonucleotide Manufacturing
Segment by Application	Pharmaceuticals Scientific Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Nippon Shokubai, Eurogentec, Ajinomoto Bio-Pharma, PeptiStar, Bachem, CordenPharma, Guangzhou RiboBio, Hongene Biotech, WuXi AppTec, Veliter, Ribobay Pharma, ChemExpress, Asymchem
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Process Development and Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oligonucleotide Process Development and Manufacturing Market growing?

Ans: The Oligonucleotide Process Development and Manufacturing Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Oligonucleotide Process Development and Manufacturing Market size in 2031?

Ans: The Oligonucleotide Process Development and Manufacturing Market size in 2031 will be US$ 2148 million.

Who are the main players in the Oligonucleotide Process Development and Manufacturing Market report?

Ans: The main players in the Oligonucleotide Process Development and Manufacturing Market are ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Nippon Shokubai, Eurogentec, Ajinomoto Bio-Pharma, PeptiStar, Bachem, CordenPharma, Guangzhou RiboBio, Hongene Biotech, WuXi AppTec, Veliter, Ribobay Pharma, ChemExpress, Asymchem

What are the Application segmentation covered in the Oligonucleotide Process Development and Manufacturing Market report?

Ans: The Applications covered in the Oligonucleotide Process Development and Manufacturing Market report are Pharmaceuticals, Scientific Research

What are the Type segmentation covered in the Oligonucleotide Process Development and Manufacturing Market report?

Ans: The Types covered in the Oligonucleotide Process Development and Manufacturing Market report are Oligonucleotide Process Development, Oligonucleotide Manufacturing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oligonucleotide Process Development

1.2.3 Oligonucleotide Manufacturing

1.3 Market by Application

1.3.1 Global Oligonucleotide Process Development and Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceuticals

1.3.3 Scientific Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oligonucleotide Process Development and Manufacturing Market Perspective (2020-2031)

2.2 Global Oligonucleotide Process Development and Manufacturing Growth Trends by Region

2.2.1 Global Oligonucleotide Process Development and Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oligonucleotide Process Development and Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Oligonucleotide Process Development and Manufacturing Market Dynamics

2.3.1 Oligonucleotide Process Development and Manufacturing Industry Trends

2.3.2 Oligonucleotide Process Development and Manufacturing Market Drivers

2.3.3 Oligonucleotide Process Development and Manufacturing Market Challenges

2.3.4 Oligonucleotide Process Development and Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oligonucleotide Process Development and Manufacturing Players by Revenue

3.1.1 Global Top Oligonucleotide Process Development and Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Top Oligonucleotide Process Development and Manufacturing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oligonucleotide Process Development and Manufacturing Revenue

3.4 Global Oligonucleotide Process Development and Manufacturing Market Concentration Ratio

3.4.1 Global Oligonucleotide Process Development and Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Process Development and Manufacturing Revenue in 2024

3.5 Global Key Players of Oligonucleotide Process Development and Manufacturing Head office and Area Served

3.6 Global Key Players of Oligonucleotide Process Development and Manufacturing, Product and Application

3.7 Global Key Players of Oligonucleotide Process Development and Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oligonucleotide Process Development and Manufacturing Breakdown Data by Type

4.1 Global Oligonucleotide Process Development and Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Type (2026-2031)

5 Oligonucleotide Process Development and Manufacturing Breakdown Data by Application

5.1 Global Oligonucleotide Process Development and Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)

6.2 North America Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)

6.4 North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)

7.2 Europe Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)

7.4 Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)

9.2 Latin America Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ST Pharm

11.1.1 ST Pharm Company Details

11.1.2 ST Pharm Business Overview

11.1.3 ST Pharm Oligonucleotide Process Development and Manufacturing Introduction

11.1.4 ST Pharm Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.1.5 ST Pharm Recent Development

11.2 EUROAPI

11.2.1 EUROAPI Company Details

11.2.2 EUROAPI Business Overview

11.2.3 EUROAPI Oligonucleotide Process Development and Manufacturing Introduction

11.2.4 EUROAPI Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.2.5 EUROAPI Recent Development

11.3 Danaher(IDT)

11.3.1 Danaher(IDT) Company Details

11.3.2 Danaher(IDT) Business Overview

11.3.3 Danaher(IDT) Oligonucleotide Process Development and Manufacturing Introduction

11.3.4 Danaher(IDT) Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.3.5 Danaher(IDT) Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Oligonucleotide Process Development and Manufacturing Introduction

11.4.4 Merck Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Eurofins Scientific

11.5.1 Eurofins Scientific Company Details

11.5.2 Eurofins Scientific Business Overview

11.5.3 Eurofins Scientific Oligonucleotide Process Development and Manufacturing Introduction

11.5.4 Eurofins Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.5.5 Eurofins Scientific Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Details

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Introduction

11.6.4 Thermo Fisher Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Agilent Technologies

11.7.1 Agilent Technologies Company Details

11.7.2 Agilent Technologies Business Overview

11.7.3 Agilent Technologies Oligonucleotide Process Development and Manufacturing Introduction

11.7.4 Agilent Technologies Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.7.5 Agilent Technologies Recent Development

11.8 Nippon Shokubai

11.8.1 Nippon Shokubai Company Details

11.8.2 Nippon Shokubai Business Overview

11.8.3 Nippon Shokubai Oligonucleotide Process Development and Manufacturing Introduction

11.8.4 Nippon Shokubai Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.8.5 Nippon Shokubai Recent Development

11.9 Eurogentec

11.9.1 Eurogentec Company Details

11.9.2 Eurogentec Business Overview

11.9.3 Eurogentec Oligonucleotide Process Development and Manufacturing Introduction

11.9.4 Eurogentec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.9.5 Eurogentec Recent Development

11.10 Ajinomoto Bio-Pharma

11.10.1 Ajinomoto Bio-Pharma Company Details

11.10.2 Ajinomoto Bio-Pharma Business Overview

11.10.3 Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Introduction

11.10.4 Ajinomoto Bio-Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.10.5 Ajinomoto Bio-Pharma Recent Development

11.11 PeptiStar

11.11.1 PeptiStar Company Details

11.11.2 PeptiStar Business Overview

11.11.3 PeptiStar Oligonucleotide Process Development and Manufacturing Introduction

11.11.4 PeptiStar Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.11.5 PeptiStar Recent Development

11.12 Bachem

11.12.1 Bachem Company Details

11.12.2 Bachem Business Overview

11.12.3 Bachem Oligonucleotide Process Development and Manufacturing Introduction

11.12.4 Bachem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.12.5 Bachem Recent Development

11.13 CordenPharma

11.13.1 CordenPharma Company Details

11.13.2 CordenPharma Business Overview

11.13.3 CordenPharma Oligonucleotide Process Development and Manufacturing Introduction

11.13.4 CordenPharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.13.5 CordenPharma Recent Development

11.14 Guangzhou RiboBio

11.14.1 Guangzhou RiboBio Company Details

11.14.2 Guangzhou RiboBio Business Overview

11.14.3 Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Introduction

11.14.4 Guangzhou RiboBio Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.14.5 Guangzhou RiboBio Recent Development

11.15 Hongene Biotech

11.15.1 Hongene Biotech Company Details

11.15.2 Hongene Biotech Business Overview

11.15.3 Hongene Biotech Oligonucleotide Process Development and Manufacturing Introduction

11.15.4 Hongene Biotech Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.15.5 Hongene Biotech Recent Development

11.16 WuXi AppTec

11.16.1 WuXi AppTec Company Details

11.16.2 WuXi AppTec Business Overview

11.16.3 WuXi AppTec Oligonucleotide Process Development and Manufacturing Introduction

11.16.4 WuXi AppTec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.16.5 WuXi AppTec Recent Development

11.17 Veliter

11.17.1 Veliter Company Details

11.17.2 Veliter Business Overview

11.17.3 Veliter Oligonucleotide Process Development and Manufacturing Introduction

11.17.4 Veliter Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.17.5 Veliter Recent Development

11.18 Ribobay Pharma

11.18.1 Ribobay Pharma Company Details

11.18.2 Ribobay Pharma Business Overview

11.18.3 Ribobay Pharma Oligonucleotide Process Development and Manufacturing Introduction

11.18.4 Ribobay Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.18.5 Ribobay Pharma Recent Development

11.19 ChemExpress

11.19.1 ChemExpress Company Details

11.19.2 ChemExpress Business Overview

11.19.3 ChemExpress Oligonucleotide Process Development and Manufacturing Introduction

11.19.4 ChemExpress Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.19.5 ChemExpress Recent Development

11.20 Asymchem

11.20.1 Asymchem Company Details

11.20.2 Asymchem Business Overview

11.20.3 Asymchem Oligonucleotide Process Development and Manufacturing Introduction

11.20.4 Asymchem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

11.20.5 Asymchem Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oligonucleotide Process Development

Table 3. Key Players of Oligonucleotide Manufacturing

Table 4. Global Oligonucleotide Process Development and Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Oligonucleotide Process Development and Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Oligonucleotide Process Development and Manufacturing Market Share by Region (2020-2025)

Table 8. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Oligonucleotide Process Development and Manufacturing Market Share by Region (2026-2031)

Table 10. Oligonucleotide Process Development and Manufacturing Market Trends

Table 11. Oligonucleotide Process Development and Manufacturing Market Drivers

Table 12. Oligonucleotide Process Development and Manufacturing Market Challenges

Table 13. Oligonucleotide Process Development and Manufacturing Market Restraints

Table 14. Global Oligonucleotide Process Development and Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Oligonucleotide Process Development and Manufacturing Market Share by Players (2020-2025)

Table 16. Global Top Oligonucleotide Process Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Process Development and Manufacturing as of 2024)

Table 17. Ranking of Global Top Oligonucleotide Process Development and Manufacturing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Oligonucleotide Process Development and Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Oligonucleotide Process Development and Manufacturing, Headquarters and Area Served

Table 20. Global Key Players of Oligonucleotide Process Development and Manufacturing, Product and Application

Table 21. Global Key Players of Oligonucleotide Process Development and Manufacturing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Type (2020-2025)

Table 25. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Type (2026-2031)

Table 27. Global Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Application (2020-2025)

Table 29. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Application (2026-2031)

Table 31. North America Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 46. ST Pharm Company Details

Table 47. ST Pharm Business Overview

Table 48. ST Pharm Oligonucleotide Process Development and Manufacturing Product

Table 49. ST Pharm Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 50. ST Pharm Recent Development

Table 51. EUROAPI Company Details

Table 52. EUROAPI Business Overview

Table 53. EUROAPI Oligonucleotide Process Development and Manufacturing Product

Table 54. EUROAPI Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 55. EUROAPI Recent Development

Table 56. Danaher(IDT) Company Details

Table 57. Danaher(IDT) Business Overview

Table 58. Danaher(IDT) Oligonucleotide Process Development and Manufacturing Product

Table 59. Danaher(IDT) Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 60. Danaher(IDT) Recent Development

Table 61. Merck Company Details

Table 62. Merck Business Overview

Table 63. Merck Oligonucleotide Process Development and Manufacturing Product

Table 64. Merck Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 65. Merck Recent Development

Table 66. Eurofins Scientific Company Details

Table 67. Eurofins Scientific Business Overview

Table 68. Eurofins Scientific Oligonucleotide Process Development and Manufacturing Product

Table 69. Eurofins Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 70. Eurofins Scientific Recent Development

Table 71. Thermo Fisher Scientific Company Details

Table 72. Thermo Fisher Scientific Business Overview

Table 73. Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Product

Table 74. Thermo Fisher Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 75. Thermo Fisher Scientific Recent Development

Table 76. Agilent Technologies Company Details

Table 77. Agilent Technologies Business Overview

Table 78. Agilent Technologies Oligonucleotide Process Development and Manufacturing Product

Table 79. Agilent Technologies Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 80. Agilent Technologies Recent Development

Table 81. Nippon Shokubai Company Details

Table 82. Nippon Shokubai Business Overview

Table 83. Nippon Shokubai Oligonucleotide Process Development and Manufacturing Product

Table 84. Nippon Shokubai Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 85. Nippon Shokubai Recent Development

Table 86. Eurogentec Company Details

Table 87. Eurogentec Business Overview

Table 88. Eurogentec Oligonucleotide Process Development and Manufacturing Product

Table 89. Eurogentec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 90. Eurogentec Recent Development

Table 91. Ajinomoto Bio-Pharma Company Details

Table 92. Ajinomoto Bio-Pharma Business Overview

Table 93. Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Product

Table 94. Ajinomoto Bio-Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 95. Ajinomoto Bio-Pharma Recent Development

Table 96. PeptiStar Company Details

Table 97. PeptiStar Business Overview

Table 98. PeptiStar Oligonucleotide Process Development and Manufacturing Product

Table 99. PeptiStar Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 100. PeptiStar Recent Development

Table 101. Bachem Company Details

Table 102. Bachem Business Overview

Table 103. Bachem Oligonucleotide Process Development and Manufacturing Product

Table 104. Bachem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 105. Bachem Recent Development

Table 106. CordenPharma Company Details

Table 107. CordenPharma Business Overview

Table 108. CordenPharma Oligonucleotide Process Development and Manufacturing Product

Table 109. CordenPharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 110. CordenPharma Recent Development

Table 111. Guangzhou RiboBio Company Details

Table 112. Guangzhou RiboBio Business Overview

Table 113. Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Product

Table 114. Guangzhou RiboBio Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 115. Guangzhou RiboBio Recent Development

Table 116. Hongene Biotech Company Details

Table 117. Hongene Biotech Business Overview

Table 118. Hongene Biotech Oligonucleotide Process Development and Manufacturing Product

Table 119. Hongene Biotech Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 120. Hongene Biotech Recent Development

Table 121. WuXi AppTec Company Details

Table 122. WuXi AppTec Business Overview

Table 123. WuXi AppTec Oligonucleotide Process Development and Manufacturing Product

Table 124. WuXi AppTec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 125. WuXi AppTec Recent Development

Table 126. Veliter Company Details

Table 127. Veliter Business Overview

Table 128. Veliter Oligonucleotide Process Development and Manufacturing Product

Table 129. Veliter Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 130. Veliter Recent Development

Table 131. Ribobay Pharma Company Details

Table 132. Ribobay Pharma Business Overview

Table 133. Ribobay Pharma Oligonucleotide Process Development and Manufacturing Product

Table 134. Ribobay Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 135. Ribobay Pharma Recent Development

Table 136. ChemExpress Company Details

Table 137. ChemExpress Business Overview

Table 138. ChemExpress Oligonucleotide Process Development and Manufacturing Product

Table 139. ChemExpress Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 140. ChemExpress Recent Development

Table 141. Asymchem Company Details

Table 142. Asymchem Business Overview

Table 143. Asymchem Oligonucleotide Process Development and Manufacturing Product

Table 144. Asymchem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 145. Asymchem Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. Oligonucleotide Process Development and Manufacturing Picture

Figure 2. Global Oligonucleotide Process Development and Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oligonucleotide Process Development and Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. Oligonucleotide Process Development Features

Figure 5. Oligonucleotide Manufacturing Features

Figure 6. Global Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Oligonucleotide Process Development and Manufacturing Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceuticals Case Studies

Figure 9. Scientific Research Case Studies

Figure 10. Oligonucleotide Process Development and Manufacturing Report Years Considered

Figure 11. Global Oligonucleotide Process Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Oligonucleotide Process Development and Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Oligonucleotide Process Development and Manufacturing Market Share by Region: 2024 VS 2031

Figure 14. Global Oligonucleotide Process Development and Manufacturing Market Share by Players in 2024

Figure 15. Global Oligonucleotide Process Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Oligonucleotide Process Development and Manufacturing Revenue in 2024

Figure 17. North America Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)

Figure 19. United States Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)

Figure 23. Germany Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Share by Region (2020-2031)

Figure 31. China Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)

Figure 39. Mexico Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)

Figure 43. Turkey Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. ST Pharm Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 47. EUROAPI Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 48. Danaher(IDT) Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 49. Merck Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 50. Eurofins Scientific Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 52. Agilent Technologies Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 53. Nippon Shokubai Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 54. Eurogentec Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 55. Ajinomoto Bio-Pharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 56. PeptiStar Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 57. Bachem Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 58. CordenPharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 59. Guangzhou RiboBio Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 60. Hongene Biotech Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 61. WuXi AppTec Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 62. Veliter Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 63. Ribobay Pharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 64. ChemExpress Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 65. Asymchem Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oligonucleotide Therapeutics Market Research Report 2024

Global Oligonucleotides Market Insights Forecast to 2030

Global Oligonucleotide Market Research Report 2025

Global Oligonucleotide Drug Carriers Market Research Report 2024

Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide and Oligonucleotide Drugs Market Research Report 2024

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Global Large Scale Oligonucleotide Synthesis Services Market Research Report 2025

Global DNA Oligonucleotide Synthesis Market Insights Forecast to 2030

Global Oligonucleotide Synthesis Services Market Insights Forecast to 2030

Global Oligonucleotide Drug Delivery Market Research Report 2024

Global Oligonucleotide Purification Market Research Report 2025

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global Oligonucleotide Therapy based Drug Market Research Report 2024

Global Oligonucleotide based Therapy Medicinal Product Market Research Report 2024

DNA RNA Oligonucleotides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oligonucleotide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide CDMO Market Research Report 2025

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Oligonucleotide Process Development and Manufacturing Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-7A19364

Global Oligonucleotide Process Development and Manufacturing Market Research Report 2025

FEATURED COMPANIES

Oligonucleotide Process Development and Manufacturing Market Size

Oligonucleotide Process Development and Manufacturing Market

Scope of Oligonucleotide Process Development and Manufacturing Market Report

Chapter Outline

FAQ for this report

How fast is Oligonucleotide Process Development and Manufacturing Market growing?

What is the Oligonucleotide Process Development and Manufacturing Market size in 2031?

Who are the main players in the Oligonucleotide Process Development and Manufacturing Market report?

What are the Application segmentation covered in the Oligonucleotide Process Development and Manufacturing Market report?

What are the Type segmentation covered in the Oligonucleotide Process Development and Manufacturing Market report?

FEATURED COMPANIES

RELATED REPORTS

Genomics Market

Single User, Electronic (PDF)

Global mHealth Apps Market Size Status and Forecast 2021 to 2027

Single User, Electronic (PDF)